CRIS Current Research Information System

CARACENI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 16.349
NA - Nord America 15.401
EU - Europa 12.167
SA - Sud America 937
AF - Africa 795
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 12
Totale 45.682
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.217
VN - Vietnam 5.071
SG - Singapore 3.993
CN - Cina 3.763
IT - Italia 3.471
GB - Regno Unito 2.145
DE - Germania 1.297
HK - Hong Kong 1.269
SE - Svezia 1.188
FR - Francia 768
IN - India 699
BR - Brasile 635
RU - Federazione Russa 526
NL - Olanda 491
UA - Ucraina 432
IE - Irlanda 377
KR - Corea 330
CH - Svizzera 282
FI - Finlandia 281
JP - Giappone 250
BG - Bulgaria 231
TG - Togo 222
ZA - Sudafrica 218
CI - Costa d'Avorio 169
EE - Estonia 160
JO - Giordania 117
PH - Filippine 106
AR - Argentina 103
ES - Italia 100
AT - Austria 97
BD - Bangladesh 95
CA - Canada 94
TH - Thailandia 89
ID - Indonesia 84
IR - Iran 63
BE - Belgio 62
TR - Turchia 62
IQ - Iraq 61
PL - Polonia 61
MX - Messico 59
SC - Seychelles 57
EC - Ecuador 56
PK - Pakistan 45
TW - Taiwan 44
CL - Cile 43
SA - Arabia Saudita 37
UZ - Uzbekistan 37
GR - Grecia 34
CO - Colombia 32
HR - Croazia 28
MY - Malesia 26
NG - Nigeria 22
VE - Venezuela 22
CZ - Repubblica Ceca 21
PY - Paraguay 20
EG - Egitto 17
ET - Etiopia 17
IL - Israele 17
LT - Lituania 17
AU - Australia 16
NP - Nepal 16
PT - Portogallo 16
MA - Marocco 15
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
LB - Libano 13
PE - Perù 13
RO - Romania 13
DZ - Algeria 12
AL - Albania 10
KE - Kenya 10
OM - Oman 10
RS - Serbia 9
KZ - Kazakistan 8
UY - Uruguay 7
CR - Costa Rica 6
EU - Europa 6
HU - Ungheria 6
CD - Congo 5
DO - Repubblica Dominicana 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
HN - Honduras 4
KG - Kirghizistan 4
LU - Lussemburgo 4
LV - Lettonia 4
MK - Macedonia 4
MN - Mongolia 4
MU - Mauritius 4
NO - Norvegia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SI - Slovenia 4
SV - El Salvador 4
Totale 45.638
Salva come PNG Salva come JPEG
Città #
Singapore 2.718
Southend 1.824
Ashburn 1.654
Fairfield 1.434
Hong Kong 1.172
Chandler 1.137
Ho Chi Minh City 1.041
Hanoi 973
Dong Ket 773
San Jose 733
Santa Clara 733
Woodbridge 717
Hefei 661
Wilmington 643
Bologna 626
Seattle 620
Houston 604
Cambridge 547
Princeton 493
Beijing 458
Boardman 380
Dublin 373
Ann Arbor 352
Los Angeles 295
Milan 272
Seoul 267
Lauterbourg 265
Bern 247
Jacksonville 229
Sofia 227
Lomé 222
Dallas 216
Helsinki 213
Tokyo 206
Nanjing 201
Westminster 187
Padova 182
New York 178
Da Nang 172
Abidjan 169
Rome 147
Berlin 146
Haiphong 144
Council Bluffs 121
Amman 116
Buffalo 116
Jinan 113
Shenyang 111
Frankfurt am Main 103
Florence 102
Saint Petersburg 97
Guangzhou 94
Redondo Beach 91
San Diego 91
Turin 90
Shanghai 85
Munich 82
Changsha 81
Redmond 77
São Paulo 71
Bengaluru 70
Medford 64
Hải Dương 61
Nuremberg 61
Nanchang 60
Chicago 56
Brussels 55
London 55
Mülheim 55
Biên Hòa 54
Hebei 54
Vienna 54
Dearborn 52
Tianjin 50
Amsterdam 49
Zhengzhou 49
Bremen 47
Falkenstein 46
Bangkok 44
Can Tho 44
Hangzhou 44
Jakarta 44
Jiaxing 43
Paris 43
Johannesburg 42
Redwood City 41
Naples 40
Warsaw 38
Des Moines 37
Lappeenranta 37
Ningbo 35
Falls Church 33
Orem 33
Montreal 31
Ninh Bình 31
Bến Tre 30
Chennai 30
Norwalk 30
Olalla 30
Phoenix 30
Totale 28.294
Salva come PNG Salva come JPEG
Nome #
L’arterializzazione della vena porta per insuffcienza epatica acuta 700
Arterializzazione della vena porta per il trattamento dell’insufficenza epatica acuta secondaria ad estesa resezione epatica nel ratto. 460
Le alterazioni dell’emodinamica sistemica e distrettuale come fattori patogenetici nella cirrosi scompensata. 361
OS-077 Single-cell RNA sequencing of peripheral blood mononuclear cells in patients with acutely decompensated cirrhosis reveals a specific monocyte subset associated with an increased risk of progression to ACLF 347
L’albumina nelle malattie del fegato. 326
Acute Liver Failure Caused by Amanita phalloides Poisoning 299
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 293
Monofocal hepatocellular carcinoma: How much does size matter? 283
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 269
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 260
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 252
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 249
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 246
Dossier Epatologia: Sindrome epatopolmonare e ipertensione portopolmonare. 243
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 239
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 239
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 238
Pattern of macrovascular invasion in hepatocellular carcinoma 233
A case of pneumonia and sepsis in cirrhosis as paradigm of the problems in the management of bacterial infections in cirrhosis and of the limitations of current knowledge 232
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 230
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 229
A novel model of CCl4-induced cirrosi with ascites in the mouse. 222
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 220
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 218
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 216
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 216
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 216
Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation 215
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 215
Portal vein arterialization in a patient with acute liver failure 214
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 213
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 213
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 212
569 ENDOCANNABINOIDS AND CIRRHOSIS: HAVE WE PICKED THE RIGHT ONE? 212
Albumin administration in internal medicine: A journey between effectiveness and futility 212
First report of fulminant hepatic failure treated with portal v ein arterialization avoiding liver transplantation 211
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 211
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? 210
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 209
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 208
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 205
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 205
L’iponatremia nel paziente con cirrosi epatica. 204
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 203
Clinical indications for the albumin use: Still a controversial issue. 203
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 201
The changing scenario of hepatocellular carcinoma in Italy: an update 200
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 199
Outcomes of patients with alcohol-related cirrhosis referred to a hepatology outpatient clinic 197
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 197
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 197
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 197
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 196
Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis 195
Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study 194
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 194
Cardiac electrophysiological abnormalities in patients with cirrhosis. 194
Metabolic disorders across hepatocellular carcinoma in Italy 193
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 193
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 192
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 192
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 192
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 192
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) 191
Linee-guida per l’uso clinico dell’albumina: l’esperienza del Policlinico S. Orsola-Mallpighi di Bologna. 191
Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation. 190
Real-word experience of long-term albumin treatment in a large cohort of patients with cirrhosis and ascites (Real-Answer study) 189
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 189
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 189
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 189
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 188
The analysis of food intake in patients with cirrhosis waiting for liver transplantation: A neglected step in the nutritional assessment 188
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 187
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib 186
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 186
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 186
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 186
Hyperoxia fully protects mitochondria of explanted livers 186
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 186
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 185
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 185
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 184
A case of prolonged cholestatic hepatitis induced by azithromycin in a young woman 184
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial 183
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 182
CCL4-induced acute liver failure with portal vein arterialization in the rat 182
Insufficienza epatica acuta ed epatite subacuta. 182
Soluble Receptor Activator of Nuclear Factor-kB Ligand (sRANKL)/Osteoprotegerin balance in ageing and age-associated diseases. 181
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 181
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 180
Complicanze della cirrosi epatica: le infezioni batteriche. 179
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 179
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 176
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 175
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 175
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 173
Incidence and clinical implications of abstinence-induced hepatic recompensation in decompensated alcohol-related cirrhosis 172
Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study 171
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 171
Totale 21.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.816
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.744 0 0 0 0 0 0 0 0 0 205 166 1.373
2021/20224.776 410 158 317 369 405 248 155 391 186 274 1.163 700
2022/20235.219 505 753 284 601 321 429 177 294 864 167 402 422
2023/20241.931 122 265 119 190 122 386 112 145 72 143 158 97
2024/20257.029 295 993 570 557 1.063 382 406 229 197 545 367 1.425
2025/202616.281 1.499 1.488 1.509 1.208 1.679 937 2.583 581 3.466 1.331 0 0
Totale 46.626